# Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

> **NCT01697644** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 75 (actual)

## Conditions studied

- Foetal Growth Problem
- Small for Gestational Age

## Interventions

- **DRUG:** somatropin
- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT01697644
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1990-10
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01697644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01697644, "Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01697644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*